Merck Expands Manufacturing Site In China As Part Of Its Global Restructuring Program
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Merck announced it would invest $162 million to expand its capacity in China by building a new manufacturing facility, shortly after the company detailed its plans to integrate its R&D, manufacturing and business operations worldwide